Empresario argentino comprometido con el desarrollo de la industria nacional de su país, dedicado principalmente a la industria farmacéutica, con participación en el rubro bancario y de seguros. Actualmente es presidente de Laboratorios Richmond.

Notas recomendadas

¿El fin del HIV-SIDA está a nuestro alcance?

Hoy, los esfuerzos para combatir la epidemia se centran en aumentar la detección de personas que viven con VIH para acceder a tratamientos y reducir la transmisión del virus. El estatus en la Argentina y una radiografía de los grupos más vulnerables en un diálogo entre expertos.
Ver más

Why Are So Few Blockbuster Drugs Invented Today?

In the fall of 1999, a young chemical engineer named Todd Zion left his job at Eastman Kodak to enroll in the Ph.D. program at the Massachusetts Institute of Technology. While looking for a subject to research, Zion noticed a grant proposal, never funded, that another graduate student had written on the subject of drug delivery.
Ver más

HIV treatment successes lead to new challenges, opportunities in confronting chronic disease

From Science Speaks: “Every continent has seen the success of [anti-HIV efforts] in dropping numbers of new infections, dropping rates of death from the disease, and longer productive life spans.
Ver más

Should experimental drugs be used in the Ebola outbreak?

Nature examines the risks and benefits of unproven Ebola treatments, as World Health Organization says it is ethical to use them in West African crisis.
Ver más

Drogas para el cáncer con precios incomprensibles en USA y Europa

Cancer drug prices keep rising. The industry says this reflects the rising costs of drug development and the business risks they must take when testing new drugs. I think they charge what they think they can get away with, which goes up every year.
Ver más

Research training: Homeward bound

South American efforts to repatriate scientists are paying off.
Ver más

Capacity building: Architects of South American science

Ten research leaders call for policies to build science, and ways to build science into policy.
Ver más

Fellowships: Turning brain drain into brain circulation

Overseas scholarships that encourage scientists to return to their home countries are helping to rebuild science in Latin America, says Torsten Wiesel.
Ver más

The impact gap: South America by the numbers

The expanding economies of South America have led to a significant rise in scientific output over the past two decades, and research spending has increased in most countries. But given the region’s share of the world’s population and gross domestic product (GDP), publication rates still fall short of what would be expected.
Ver más